DdrA, DdrD, and PprA: components of UV and mitomycin C resistance in Deinococcus radiodurans R1

PLoS One. 2013 Jul 1;8(7):e69007. doi: 10.1371/journal.pone.0069007. Print 2013.

Abstract

Mutants created by deleting the ddrA, ddrB, ddrC, ddrD, and pprA loci of Deinococcus radiodurans R1alone and in all possible combinations of pairs revealed that the encoded gene products contribute to this species' resistance to UV light and/or mitomycin C. Deleting pprA from an otherwise wild type cell sensitizes the resulting strain to UV irradiation, reducing viability by as much as eight fold relative to R1. If this deletion is introduced into a ΔddrA or ΔddrD background, the resulting strains become profoundly sensitive to the lethal effects of UV light. At a fluence of 1000 Jm⁻², the ΔddrA ΔpprA and ΔddrD ΔpprA strains are 100- and 1000-fold more sensitive to UV relative to the strain that has only lost pprA. Deletion of ddrA results in a 100 fold increase in strain sensitivity to mitomycin C, but in backgrounds that combine a deletion of ddrA with deletions of either ddrC or ddrD, mitomycin resistance is restored to wild type levels. Inactivation of ddrB also increases D. radiodurans sensitivity to mitomycin, but unlike the ddrA mutant deleting ddrC or ddrD from a ΔddrB background further increases that sensitivity. Despite the effect that loss of these gene products has on DNA damage resistance, none appear to directly affect either excision repair or homologous recombination suggesting that they participate in novel processes that facilitate tolerance to UV light and interstrand crosslinks in this species.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics*
  • Deinococcus / cytology
  • Deinococcus / drug effects*
  • Deinococcus / genetics
  • Deinococcus / radiation effects*
  • Gene Deletion
  • Genes, Bacterial*
  • Microbial Viability / drug effects
  • Microbial Viability / radiation effects
  • Mitomycin / pharmacology*
  • Ultraviolet Rays

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Mitomycin

Grants and funding

This work was supported by Grant DEFG0201ER63151 from the United States Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.